Related Experiment Video

Updated: Aug 23, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Cigarette smoking increases plasma concentrations of vascular cell adhesion molecule-1 in patients with coronary

Yuksel Cavusoglu1, Bilgin Timuralp, Tercan Us

  • 1Department of Cardiology, Faculty of Medicine, Osmangazi University, Eskisehir, Turkey. yukselc@ogu.edu.tr

Angiology
|July 20, 2004
PubMed

Insights

Cigarette smoking significantly increases soluble vascular cell adhesion molecule-1 (VCAM-1) levels in coronary artery disease (CAD) patients. This finding suggests smoking accelerates atherosclerosis by promoting inflammatory cell adhesion.

Area of Science:

  • Cardiovascular Disease Research
  • Inflammation and Immunology
  • Atherosclerosis Pathogenesis

Background:

  • Cigarette smoking negatively impacts endothelial function and elevates coronary artery disease (CAD) risk.
  • Atherosclerosis pathogenesis involves inflammatory cell-endothelial interactions, with adhesion molecules playing a key role.
  • The specific impact of smoking on these inflammatory processes in CAD remains under-investigated.

Purpose of the Study:

  • To investigate the effect of cigarette smoking on plasma concentrations of soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with CAD.
  • To explore potential mechanisms linking smoking to accelerated atherosclerotic processes.

Main Methods:

  • Quantification of soluble VCAM-1 plasma levels using enzyme-linked immunosorbent assay (ELISA).
  • Comparison of soluble VCAM-1 levels between smoking CAD patients (n=19) and non-smoking CAD patients (n=10).
  • Analysis of soluble VCAM-1 levels in relation to patient history of myocardial infarction (MI), hypertension, and disease severity.

Main Results:

  • Soluble VCAM-1 levels were significantly higher in smoking CAD patients compared to non-smokers (32.13 vs 9.46 ng/mL, p < 0.01).
  • A trend towards higher soluble VCAM-1 was observed in patients with prior MI, though not statistically significant.
  • No significant differences in soluble VCAM-1 were found based on hypertension, vessel disease extent, or MI localization.

Conclusions:

  • Smoking elevates soluble VCAM-1 levels in CAD patients, indicating increased endothelial adhesion molecule expression.
  • Elevated soluble VCAM-1 in smokers may represent a key mechanism by which smoking accelerates atherosclerosis.
  • Further research is warranted to elucidate the full impact of smoking-induced inflammation on cardiovascular disease progression.

More Related Videos

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface10:47

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface

Published on: February 21, 2011

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...